Please provide your email address to receive an email when new articles are posted on . Outset Medical halts sales of medical cart to obtain FDA 510(k) approval. The company released its ...

Dialysis tech company Outset Medical appears to have put the cart before the horse, so to speak. The "cart" in this case being quite literal – the TabloCart – and the "horse" being metaphorical for ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The announcement notice comes after Outset paused ...

Outset Medical today announced the FDA 510(k) clearance of its TabloCart with prefiltration, an optional accessory for the Tablo Hemodialysis system. Tablo, which can be used for outpatient, hospital, ...

Outset Medical's financial trajectory has shown signs of improvement, despite facing challenges. In its Q3 2024 earnings report, the company surpassed expectations and subsequently raised its 2024 ...

Outset Medical (NASDAQ:OM) lost nearly 64% on Thursday to reach a new 52-week low after the maker of Tablo Hemodialysis System missed estimates with its Q2 2024 financials, leading to a downgrade at ...

Good day, and thank you for standing by. Welcome to the Outset Medical Q3 2023 Earnings Conference Call. [Operator Instructions]. Please be advised that today's conference is being recorded. I would ...

Outset Medical (TASE:PMCN), Inc. (NASDAQ:OM), a medical technology company specializing in dialysis solutions with a market capitalization of $63.58 million, has recently undergone significant changes ...